AP NEWS

Medpace Holdings, Inc. to Report Third Quarter 2018 Financial Results on October 29, 2018

October 3, 2018

CINCINNATI--(BUSINESS WIRE)--Oct 3, 2018--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2018 financial results after the market close on Monday, October 29, 2018. The Company will host a conference call the following morning, Tuesday, October 30, 2018, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 2282569.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

A recording of the call will be available from 12:00 p.m. ET on Tuesday, October 30, 2018 until 12:00 p.m. ET on Tuesday, November 13, 2018. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 2282569.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,700 people across 36 countries.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181003005805/en/

CONTACT: Medpace Holdings, Inc.

Media Contact:

Julie Hopkins, 513-579-9911 x12627

j.hopkins@medpace.com

or

Investor Contact:

investor@medpace.com

KEYWORD: UNITED STATES NORTH AMERICA OHIO

INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY CARDIOLOGY CLINICAL TRIALS HOSPITALS INFECTIOUS DISEASES MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL RESEARCH OTHER SCIENCE FDA SCIENCE

SOURCE: Medpace Holdings, Inc.

Copyright Business Wire 2018.

PUB: 10/03/2018 04:05 PM/DISC: 10/03/2018 04:05 PM

http://www.businesswire.com/news/home/20181003005805/en

AP RADIO
Update hourly